Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Higher doses of isotretinoin may lead to more hair loss.

Alefacept showed some effectiveness for alopecia areata but needs more research.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Isotretinoin is effective for treating dissecting cellulitis, but recurrence is common.

Current treatments for alopecia show no significant long-term benefits.

The model and estimator can predict drug exposure in kidney transplant patients well.

New compounds were found to help increase hair growth and decrease hair loss.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Minoxidil response testing helps treat hair loss effectively and safely.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.